Study reveals why some cancer therapies don’t work for all patients
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.
Impairments of this circuit may help to explain why some people with schizophrenia lose touch with reality.